BACKGROUND: @entity788 is considered to have the worst @entity189 . This retrospective study was to determine prognostic factors for survival after pancreaticoduodenectomy in @entity1 had @entity3123 . METHODS: We retrospectively studied all @entity1 who underwent @entity1726 for @entity788 originating from the head, neck or uncinate process from January 1996 to January 2011 in our center. Preoperative variables, intraoperative variables and postoperative variables were collected. RESULTS: The study included 480 @entity1 (282 males and 198 females with a median age of 53 years. At the time of analysis, 180 (37.5%) @entity1 were still alive. The median survival was 19 months. This corresponded to a 1-, 3-, and 5-year actuarial survival of 44 %, 20%, and 15% respectively. Mass size less than 2 cm (P=0.0001), lymph node ratio (P=0.0001), safety margin (P=0.0001), perineural, perivascular infiltration, age above 60 years (P=0.03), gender, preoperative @entity648 , SGPT, liver status, pre and postoperative @entity787 , CA19- 9 (P=0.0001) were significant predictors of survival. CONCLUSION: Mass size less than 2 cm, lymph node ratio, safety margin, perineural, perivascular infiltration, age above 60 years, gender, liver status, pre and postoperative @entity787 , CA19-9 are important predictors of survival in @entity1 undergoing @entity1726 for @entity788 .

Prognostic factors affecting survival after pancreaticoduodenectomy for XXXX (single center experience).

@entity1 :: ('9606', 'Species') :: ['patients'] @entity3123 :: ('MESH:C562463', 'Disease') :: ['pancreatic carcinoma'] @entity788 :: ('MESH:D010190', 'Disease') :: ['Pancreatic cancer', 'pancreatic cancer', 'pancreatic adenocarcinoma'] @entity648 :: ('MESH:D001663', 'Chemical') :: ['bilirubin'] @entity189 :: ('MESH:D002277', 'Disease') :: ['prognosis of the periampullary carcinomas'] @entity787 :: ('1084', 'Gene') :: ['CEA'] @entity1726 :: ('OMIM:168600', 'Disease') :: ['PD']
@entity788 :: (MESH:D010190,Disease) :: ['pancreatic adenocarcinoma']
